Influence of breast composition and interseed attenuation in dose calculations for post-implant assessment of permanent breast103Pd seed implant

Physics in Medicine and Biology

Volumn 55, Issue 16, 2010, Pages 4547-4561

  Afsharpour, Hossein ^a,b   Pignol, Jean Philippe ^c   Keller, Brian ^c   Carrier, Jean Francois ^d   Reniers, Brigitte ^e   Verhaegen, Frank ^e,f   Beaulieu, Luc ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d NOTRE DAME HOSPITAL   (Canada)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PALLADIUM; RADIOISOTOPE;

ADIPOSE TISSUE; ARTICLE; BRACHYTHERAPY; BREAST; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER PROGRAM; COMPUTER SIMULATION; FEMALE; HUMAN; INSTRUMENTATION; METHODOLOGY; MONTE CARLO METHOD; PATHOPHYSIOLOGY; RADIATION EXPOSURE; RADIOMETRY; REPRODUCIBILITY;

ADIPOSE TISSUE; BRACHYTHERAPY; BREAST; COMPUTER SIMULATION; FEMALE; HUMANS; MONTE CARLO METHOD; PALLADIUM; RADIOISOTOPES; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SOFTWARE;

EID: 77957717014     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/55/16/S09     Document Type: Article

References (38)

1. Afsharpour H, D'Amours M, Côté B, Carrier J F, Verhaegen F and Beaulieu L 2008 A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants Med. Phys. 35 3671-81
2. Agostinelli S et al 2003 GEANT4-a simulation toolkit Nucl. Instrum. Methods Phys. Res. A 506 250-303
3. Attix F H 2004 Introduction to Radiological Physics and Radiation Dosimetry (Weinheim: Wiley-VCH) p 307
4. Boone J M and Chavez A E 1996 Comparison of x-ray cross sections for diagnostic and therapeutic medical physics Med. Phys. 23 1997-2005
5. Carrier J F, Archambault L, Beaulieu L and Roy R 2004 Validation of Geant4, an object-oriented Monte Carlo toolkit, for simulations in medical physics Med. Phys. 31 484-92
6. Carrier J F, Beaulieu L, Therriault-Proulx F and Roy R 2006 Impact of interseed attenuation and tissue composition for permanent prostate implants Med Phys. 33 595-604
7. Carrier J F, D'Amours M, Verhaegen F, Reniers B, Martin A G, Vigneault E and Beaulieu L 2007 Postimplant dosimetry using a Monte Carlo dose calculation engine: a new clinical standard Int. J. Radiat. Oncol. Biol. Phys. 68 1190-8
8. 125I prostate implants Med. Phys. 32 2557-66
9. Deasy J O, Blanco A I and Clark V H 2003 CERR: a computational environment for radiotherapy research Med. Phys. 30 979-85
10. De Marco J J, Smathers J B, Burnison M, Ncube Q K and Solberg T D 1999 CT-based dosimetry calculations for 125I prostate implants Int. J. Radiat. Oncol. Biol. Phys. 45 1347-53
11. Dodwell D J, Povall J, Gerrard G, Eastwood A and Langlands A 1995 Skin telangiectasia: the influence of radiation dose delivery parameters in the conservative management of early breast cancer Clin. Oncol. 7 248-50
12. D'Souza W D, Thames H D and Kuban D A 2004 Dose-volume conundrum for response of prostate cancer to brachytherapy: summary of dosimetric measures and their relationship to tumor control probability Int. J. Radiat. Oncol. Biol. Phys. 58 1540-8
13. Evans R D 1995 The Atomic Nucleus (New York: McGraw-Hill) p 698
14. FDA 2002 Mammography Quality Standards Act Subpart A, Sec. 900. 2 http://www.fda.gov/Radiation-EmittingProducts/ MammographyQualityStandardsActandProgram/Regulations/ucm110906.htm
15. Furtoss C, Reniers B, Bertrand M J, Poon E, Carrier J F, Keller B, Pignol J P, Beaulieu L and Verhaegen F 2009 Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant Med. Phys. 36 1848-58
16. Hammerstein G R 1979a Depth Dose Data for Mammography in Reduced Dose Mammography ed W W Logan and E P Muntz (New York: Masson) pp 47-66
17. Hammerstein G R, Miller D W, White D R, Masterson M E, Woodard H Q and Laughlin J S 1979b Absorbed radiation dose in mammography Radiology 130 485-91
18. ICRU 1992 Photon, Electron, Proton and Neutron Interaction Data for Body Tissues Report 46 (Bethesda, MD: ICRU)
19. Keller B, Sankreacha R, Rakovitch E, O'Brien P and Pignol J P 2005 A permanent breast seed implant as partial breast radiation therapy for early-stage patients: a comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations Int. J. Radiat. Oncol. Biol. Phys. 62 358-65
20. Liu D, Poon E, Bazalova M, Reniers B, Evans M, Rusch T and Verhaegen F 2008 Spectroscopic characterization of a novel electronic brachytherapy system Phys. Med. Biol. 53 61-75
21. Meigooni A S, Bharucha Z, Yoe-Sein M and Swords K 2001 Dosimetric characteristics of the best double-wall 103Pd brachytherapy source Med. Phys. 28 2568-75
22. 125I brachytherapy implants Med. Phys. 19 385-90
23. Mobit P and Badragan I 2004 Dose perturbation effects in prostate seed implant brachytherapy with I-125 Phys. Med. Biol. 49 3171-8
24. 103Pd brachytherapy source Brachytherapy 1 110-9
25. Pignol J P, Keller B, Rakovitch E, Sankreacha R, Easton H and Que W 2006 First report of a permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer Int. J. Radiat. Oncol. Biol. Phys. 64 176-81
26. Pignol J P, Rakovitch E, Keller B, Sankreacha R and Chartier C 2009 Tolerance and acceptance results of a palladium-103 permanent breast seed implant phase I/II study Int. J. Radiat. Oncol. Biol. Phys. 73 1482-8
27. Poon E and Verhaegen F 2005 Accuracy of the photon and electron physics in GEANT4 for radiotherapy applications Med. Phys. 32 1696-711
28. Queensland Health 1999 Radiation safety standard http://www.health.qld. gov. au/radiationhealth/legislation/standards.asp
29. Rivard M J, Butler W M, De Werd L A, Huq M S, Ibbot G S, Meigooni A S, Melhus C S, Mitch M G, Nath R and Williamson J F 2007 Supplement to the 2004 update of the AAPM task group no. 43 report Med. Phys. 34 2187-205
30. Rivard M J, Coursey B M, De Werd L A, Hanson W F, Huq M S, Ibbot G S, Mitch M G, Nath R and Williamson J F 2004 Update of the AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations Med. Phys. 31 633-74
31. Rivard M J, Venselaar J and Beaulieu L 2009 The evolution of brachytherapy treatment planning Med. Phys. 36 2136-53
32. RTOG 2004 A phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma Report 95-17
33. Stanton L, Villafana T, Day J L and Lightfoot D A 1984 Dosage evaluation in mammography Radiology 150 577-84
34. Turesson I and Notter G 1986 The predictive value of skin telangiectasia for late radiation effects in different normal tissues Int. J. Radiat. Oncol. Biol. Phys. 12 603-9
35. Vicini F A et al 2007 Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy Int J. Radiat. Oncol. Biol. Phys. 69 1124-30
36. Vicini F A, Kestin L L, Edmundson G K, Jaffray D A, Wong J P, Kini V R, Chen P Y and Martinez A A 1999 Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer Int J. Radiat. Oncol. Biol. Phys. 45 803-10
37. Yaffe M J, Boone J M, Packard N, Alonzo-Proulx O, Huang S Y, Peressotti C L, Al-Mayah A and Brock K 2009 The myth of a 50-50 breast Med. Phys. 36 5437-43
38. Yub Y, Anderson L L, Li Z, Mellenberg D E, Nath R, Schell M C, Waterman F M, Wu A and Blasko J C 1999 Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64 Med. Phys. 26 2054-76